Study on clinical effects of tosufloxacin (TFLX) and the long-term low dose therapy for the prophylaxis of recurrent urinary tract infection

Forty five patients with complicated urinary tract infections were treated with tosufloxacin (TFLX) in the initial antibacterial treatment. Excellent and moderate responses were obtained in 39 patients (86.7%). No side effects were seen. Clinical efficacy and safety of long-term preventive administr...

Description complète

Détails bibliographiques

Publié dans:	Hinyokika kiyo. Acta urologica Japonica. - 1962. - 40(1994), 3 vom: 12. März, Seite 279-84
Auteur principal:	Sakurai, M (Auteur)
Autres auteurs:	Sugimura, Y, Arima, K, Kawamura, J, Saitou, K, Tajima, K, Nakano, S, Satani, H, Nagano, M, Hoshina, A
Format:	Article
Langue:	Japanese
Publié:	1994
Accès à la collection:	Hinyokika kiyo. Acta urologica Japonica
Sujets:	Clinical Trial English Abstract Journal Article Anti-Infective Agents Fluoroquinolones Naphthyridines tosufloxacin GHJ553KQPS